Horizon Bancorp’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Horizon Bancorp's BMY Position: Q1 2026 in Review
Horizon Bancorp increased its Bristol-Myers Squibb (BMY) stake by 22% in Q1 2026, buying an estimated $34.9K and bringing the position to 3,300 shares worth $200K. The position accounts for 0.1% of the portfolio, ranked #76.
Horizon Bancorp first reported a position in BMY in Q4 2019 and has held it in 17 quarters since. The position peaked at $1.42M in Q4 2019. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Horizon Bancorp held 3,300 shares of Bristol-Myers Squibb worth $200K as of Q1 2026.
- Horizon Bancorp bought 598 Bristol-Myers Squibb shares in Q1 2026, an estimated $34.9K.
- Bristol-Myers Squibb made up 0.1% of Horizon Bancorp's portfolio in Q1 2026, its #76 holding.
- Horizon Bancorp first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 17 quarters since.
- Horizon Bancorp's Bristol-Myers Squibb position peaked at $1.42M in Q4 2019.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Horizon Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.